Zai Lab Stock News

Three of the most major drugmakers with roots in China, Zai Lab Ltd (NASDAQ: ZLAB ), BeiGene Ltd (NASDAQ: BGNE ), and Hutchmed China Ltd (NASDAQ: HCM ), have been flagged by the SEC for failing to comply with a law governing US-listed companies. In statements responding to the SEC''s provisional list, all three companies suggest they expect more companies to come under regulatory scrutiny as they file their annual reports. The law causing panic is the Holding Foreign Companies Accountable Act (HFCAA). It requires the SEC to identify public companies whose auditing firms cannot be reviewed or inspected by the nonprofit Public Company Accounting Oversight Board (PCAOB) due to … Full story available on Benzinga.com

Chinese tech stocks were hammered on delisting fears, but the reaction was unwarranted. Read why Alibaba and JD.com now look attractive.

Chinese stock delisting news today has several big names in the country seeing their shares slip on fears they could be next. The post Chinese Stock Delisting News: Why Are BABA, DIDI, IQ, YUMC, ACMR,

Three of the most major drugmakers with roots in China, Zai Lab Ltd (NASDAQ: ZLAB), BeiGene Ltd (NASDAQ: BGNE), and Hutchmed China Ltd (NASDAQ: HCM), have been flagged by the SEC for failing to

All five companies fell in U.S. trading Thursday after the U.S. Securities and Exchange Commission put up a provisional list of companies that could be delisted if they don't measure up to U.S. accoun

Shares of many U.S.-listed Chinese stocks were tumbling Thursday after the Securities and Exchange Commission put out an update about foreign companies using accounting firms or branches that cannot b

Shares of Chinese pharmas Zai Lab (ZLAB) and Beigene (BGNE) are down significantly amid allegations they are in violation of a lw preventing ownership by foreign governments.

Shares of many U.S.-listed Chinese stocks tumbled Thursday after the Securities and Exchange Commission put out an update about foreign companies using accounting firms or branches that cannot be adeq

A 2020 law called the Holding Foreign Companies Accountable Act may be behind the sharp decline in a handful of U.S-traded Chinese stocks.

Zai Lab (ZLAB) has an impressive pipeline. But I will stay on the sidelines on the entire Chinese biopharmaceutical industry for now. Read more to know why.

ZLAB was founded by Samantha Du, the Big Sister of China's emerging pharma industry. The company has an impressive pipeline. Recent US pushback on Chinese drugs makes me wonder whether the current low

Zai Lab Limited (ZLAB) CEO Samantha Du on Q4 2021 Results - Earnings Call Transcript

Zai Lab Earnings Miss, Revenue Beats In Q1

Zai Lab press release (NASDAQ:ZLAB): FY GAAP EPS of -$7.58 misses by $0.73.Revenue of $144.3M (+194.5% Y/Y) misses by $3.91M.